Related Experiment Video

Updated: Jun 4, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Detection of ErbB Receptor Family Tyrosyl Phosphorylation in Ovarian Carcinoma Cells

A W Hamburger1

  • 1Division of Cell and Molecular Biology, Greenebaum Center for Cancer Research, University of Maryland, Baltimore, MD.

Methods in Molecular Medicine
|February 23, 2011
PubMed

Insights

Epidermal growth factor receptor (EGFR) family members are overexpressed in ovarian cancer. Amplification of ErbB-2 and EGFR is linked to poor prognosis, while ErbB-3 and ErbB-4 roles require further investigation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • The epidermal growth factor receptor (EGFR) family, also known as ErbB, comprises four receptor tyrosine kinases: EGFR (ErbB-1), HER2 (ErbB-2), HER3 (ErbB-3), and HER4 (ErbB-4).
  • These receptors share a common structure: an extracellular ligand-binding domain, a transmembrane domain, and an intracellular tyrosine kinase domain.
  • Overexpression of EGFR family members is a frequent event in ovarian cancer, impacting tumor development and progression.

Purpose of the Study:

  • To review the current understanding of the EGFR (ErbB) family in ovarian cancer.
  • To highlight the clinical significance of EGFR and ErbB-2 amplification and overexpression.
  • To identify knowledge gaps regarding the roles of ErbB-3 and ErbB-4 in ovarian cancer.

Main Methods:

  • Literature review of studies investigating EGFR family members in ovarian cancer.
  • Analysis of data correlating receptor expression and amplification with clinical outcomes.
  • Synthesis of information on the molecular architecture and function of ErbB receptors.

Main Results:

  • Epidermal growth factor receptor (EGFR) and ErbB-2 are frequently overexpressed in ovarian cancer.
  • Amplification and high expression levels of ErbB-2 correlate with poor clinical prognosis.
  • EGFR amplification may also possess prognostic significance, though less established than ErbB-2.

Conclusions:

  • The EGFR (ErbB) family plays a significant role in ovarian cancer pathogenesis.
  • ErbB-2 and EGFR are important targets for prognostic evaluation in ovarian cancer.
  • Further research is needed to elucidate the clinical significance of ErbB-3 and ErbB-4 in ovarian cancer.

More Related Videos

Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time14:25

Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time

Published on: May 20, 2014

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting07:54

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Published on: March 25, 2019

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...